No Data
No Data
Essence Pharmaceuticals: 2024 Semi-Annual Report Summary
Essence Pharmaceuticals: 2024 Semi-Annual Report
Jinghua Pharmaceutical Group (002349.SZ): The net income in the first half of the year was 0.135 billion yuan, a year-on-year decrease of 12.40%.
Jinghua Pharmaceutical Group (002349.SZ) announced its semi-annual report for 2024, with operating revenue of 0.72 billion yuan, a year-on-year decrease of 9.43%; net income attributable to shareholders of listed companies was 0.135 billion yuan, a year-on-year decrease of 12.40%; net income attributable to shareholders of listed companies after deducting non-recurring gains and losses was 0.128 billion yuan, a year-on-year decrease of 14.77%; basic earnings per share was 0.1663 yuan.
Jinghua Pharmaceutical's Phenobarbital Tablets Passes Drug Regulator's Consistency Evaluation
Jinghua Pharmaceutical Group (002349.SZ): Sun's company has obtained the approval notification of the listing application for indigo green, a chemical raw material for active pharmaceutical ingredients.
Jinghua Pharmaceutical Group (002349.SZ) announced on August 14th that recently, its subsidiary Jinghua Pharmaceutical Group Nantong Co., Ltd. has obtained the approval and issuance of the Chemical Raw Materials Application Approval Notice for Indocyanine Green, issued by the National Medical Products Administration. Indocyanine Green is a photosensitive dye mainly used for the diagnosis of various liver diseases such as cirrhosis, liver fibrosis, tough hepatitis, occupational and drug-induced liver diseases, to understand the degree of liver damage and its reserve function. It can also be used for choroidal vascular angiography to determine the location of choroidal diseases.
A-share noon review: Shanghai Composite Index fell 0.07%, oil & gas stocks led the gains, and the concept stocks of new crown special drugs retreated.
At the midday closing, the Shanghai Composite Index fell 0.07% to 2856.09 points, the Shenzhen Component Index fell 0.27%, and the Chinext price index fell 0.07%.
No Data
No Data